Seminars
Feb 11, 2026
PDF Seminar
C-terminal tail of MAVS dictates organelle targeting and innate immune response - Dr. Tak Wang Terence Lee (Post-doctoral Fellow)
School of Biomedical Sciences cordially invites you to join the following Post-doctoral Fellow (PDF) Seminar:
Date: 11 February 2026 (Wednesday)
Time: 4:00 pm – 4:30 pm
Venue: Seminar Room 2, G/F, Laboratory Block, 21 Sassoon Road
Host: Dr. Xiang Fang & Dr. Yolanda Liu
Light refreshments will be served. Please register via the below link by 10 February 2026 (Tuesday):
Registration: https://hku.au1.qualtrics.com/jfe/form/SV_a4ZB02clN09kqLs
C-terminal tail of MAVS dictates organelle targeting and innate immune response
Dr. Tak Wang Terence Lee (Post-doctoral Fellow)
[Supervisor: Professor Dong-Yan Jin]
MAVS is a mitochondrial and peroxisomal protein that adapts innate RNA sensing by RIG-I-like receptors to downstream signalling. MAVS aggregation is required for the propagation of activation signal, however whether this requirement varies with respect to subcellular localization remains unclear. We identified that MAVS aggregation is required for innate immune signalling triggered by mitochondrial but not peroxisomal MAVS. An aggregation-deficient mutant of peroxisomal MAVS retained its ability to induce type I interferon production. We further demonstrated that the magnitude of the activation signal and the distribution of MAVS to mitochondria and peroxisomes are governed by the tail charge at the C-terminus of MAVS. An increase in tail charge directs MAVS to peroxisomes predominantly, leading to a more modest activation of innate immune signalling. These results suggest that MAVS displays compartment-specific properties that are mechanistically and functionally distinct in RNA sensing.
All are welcome.
New Releases
Nov 25, 2025
HKUMed cracks gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with cholesterol inhibitors in neuron-infiltrated cases
Nov 6, 2025
From genes to face and skull: HKUMed uncovers key causes of congenital craniofacial abnormalities to improve prenatal detection of cleft lip and skull malformations
Aug 12, 2025
HKUMed identifies key protein in liver cancer resistance and develops inhibitor to enhance therapy and prevent cancer recurrence
Jun 24, 2025